• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,886.91 -416.72
( -0.54%)
Global Indices
Nasdaq
49,198.35 -53.37
(-0.11%)
Dow Jones
7,195.79 9.71
(0.14%)
Hang Seng
59,839.06 -698.30
(-1.15%)
Nikkei 225
10,332.91 11.82
(0.11%)
Forex
USD-INR
93.91 -0.14
(-0.15%)
EUR-INR
110.02 0.03
(0.03%)
GBP-INR
127.00 0.16
(0.13%)
JPY-INR
0.59 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Ishita Drugs & Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524400
INE806D01016
37.5752508
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.93
23.02
EPS(TTM)
Face Value()
Div & Yield %
2.97
10
0
 

zydus wellness ltd
J&K Bank gains as gross advances grow 17% YoY in Q4 FY26
Apr 06,2026
Total business stood at Rs 290,340.57 crore as of 31 March 2026, up 13.61%, compared with Rs 255,554.95 crore as of 31 March 2025.

Total deposits increased 11.30% to Rs 165,354.04 crore as of 31 March 2026, compared with Rs 148,569.46 crore as of 31 March 2025. CASA deposits rose 8.07% YoY to Rs 75,478.40 crore as of 31 March 2026.

Gross investment declined 1.55% to Rs 41,319.50 crore as of 31 March 2026, compared with Rs 41,970.20 crore as of 31 March 2025.

J&K Bank offers banking services under the three major divisions as support services, depository services, and third-party services.

The bank reported a 10.4% jump in net profit to Rs 586.73 crore on a 4.2% rise in total income to Rs 3,592.90 crore in Q3 FY26 over Q3 FY25.